skip to Main Content
R&D
About Aramchol
™
Mechanism of Action
Non-Clinical
Clinical Development
Phase IIa
Phase IIb
Publication & Posters
ABOUT
Company Profile
Leadership
Board of Directors
Scientific Advisory Board
Current Collaborations
FOR INVESTORS
Investors Center
News
Events & Presentations
SEC Filings
Quarterly and Annual Results
Stock Info
Corporate Governance
Get Alerts by Email
Investor Contact
CONTACT
Submit
Open Mobile Menu
SEC Filings
Select the filing type and date range you wish to view from the drop-down menus below.
NASDAQ
GLMD
Year
Trailing 12-Months
Calendar Year 2021
Calendar Year 2020
Calendar Year 2019
Calendar Year 2018
Calendar Year 2017
Calendar Year 2016
Calendar Year 2015
Calendar Year 2014
Calendar Year 2013
View
All Filings
Annual Filings
Current Filings
Registration Statements
Other
Form
Description
Date
Format
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Feb 18, 2021
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in HTML.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in DOC file.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in PDF file.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in XLS file.
424B5
Form of prospectus disclosing information facts events covered in both forms 424B2 424B3
Feb 18, 2021
Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.
Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.
Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.
Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Feb 16, 2021
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in HTML.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in DOC file.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in PDF file.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in XLS file.
424B5
Form of prospectus disclosing information facts events covered in both forms 424B2 424B3
Feb 16, 2021
Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.
Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.
Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.
Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Feb 16, 2021
Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.
Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.
Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.
Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13G/A
Amendment to a previously filed SC 13G
Feb 12, 2021
Open Amendment to a previously filed SC 13G in HTML.
Open Amendment to a previously filed SC 13G in DOC file.
Open Amendment to a previously filed SC 13G in PDF file.
Open Amendment to a previously filed SC 13G in XLS file.
SC 13G/A
Amendment to a previously filed SC 13G
Feb 12, 2021
Open Amendment to a previously filed SC 13G in HTML.
Open Amendment to a previously filed SC 13G in DOC file.
Open Amendment to a previously filed SC 13G in PDF file.
Open Amendment to a previously filed SC 13G in XLS file.
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Jan 26, 2021
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in HTML.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in DOC file.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in PDF file.
Open Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act in XLS file.
SC 13G/A
Amendment to a previously filed SC 13G
Jan 15, 2021
Open Amendment to a previously filed SC 13G in HTML.
Open Amendment to a previously filed SC 13G in DOC file.
Open Amendment to a previously filed SC 13G in PDF file.
Open Amendment to a previously filed SC 13G in XLS file.
Back To Top
×
×
R&D
R&D
About Aramchol
™
Mechanism of Action
Non-Clinical
Clinical Development
Phase IIa
Phase IIb
Publications & Posters
ABOUT
ABOUT
Company Profile
Leadership
Board of Directors
Scientific Advisory Board
Current Collaborations
FOR INVESTORS
CONTACT
Submit